Skip to content
healthcare.dev

Baxdela

NDC 70842-102, delafloxacin meglumine, injection, powder, lyophilized, for solution, from Melinta Therapeutics, LLC.

Product NDC
70842-102
Status
Listed
Labeler
Melinta Therapeutics, LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA208611
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70842-102 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DELAFLOXACIN MEGLUMINE300 mg/10.5mL

Pharmacologic classes

Fluoroquinolone Antibacterial [EPC]; Fluoroquinolones [CS]

Package NDCNDC-11Package
70842-102-037084201020310 VIAL, GLASS in 1 CARTON (70842-102-03) / 10.5 mL in 1 VIAL, GLASS (70842-102-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/fb77637a-88d9-4aea-958f-e270030ce30d
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=70842-102

Use it

Look up 70842-102 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70842-102 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70842-102. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.